Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,459 trials

2025-524616-11-00
Recruiting
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Phase 3 · Germany, Spain, Poland, Slovakia · 57 sites
Registry update: 9 Oct 2026
NCT07806838
Recruiting
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
Not applicable · United States · 1 site
Registry update: 4 Nov 2026
NCT07592546
Recruiting
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Phase 4 · Canada · 1 site
Registry update: 26 Oct 2026
NCT07123779
Recruiting
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Phase 1/2 · United States · 3 sites
Registry update: 30 Oct 2026
NCT07877090
Recruiting
Frontal EEG Dynamics During Anesthesia in Patients With Obesity and Normal Weight
Not applicable · 1 site
Registry update: 22 Oct 2026
NCT07618117
Recruiting
Improving Sleep Health and Circadian Timing to Support Cardiometabolic Health in Adolescents
Not applicable · United States · 1 site
Registry update: 5 Nov 2026
NCT07840729
Recruiting
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Phase 1 · China · 1 site
Registry update: 2 Nov 2026
NCT07881757
Recruiting
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Phase 3 · United States · 4 sites
Registry update: 6 Nov 2026
NCT07770152
Recruiting
Semaglutide in Youth With Autism Spectrum Disorder
Phase 4 · United States · 1 site
Registry update: 9 Nov 2026
NCT07866066
Recruiting
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Phase 3 · Canada, United States · 8 sites
Registry update: 5 Nov 2026
NCT07876531
Recruiting
A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
Phase 1 · United States · 1 site
Registry update: 6 Nov 2026
NCT07881458
Recruiting
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Phase 3 · Brazil, China, Germany, Spain, Japan, South Korea, Puerto Rico, Romania, Taiwan, United States · 75 sites
Registry update: 4 Nov 2026
NCT07873645
Recruiting
Study of UBT37034 Injection
Phase 1 · China · 1 site
Registry update: 5 Nov 2026
NCT07871409
Recruiting
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
Phase 3 · Puerto Rico, United States · 25 sites
Registry update: 9 Nov 2026
NCT07924956
Recruiting
Explore the Weight Loss Effect of Amway "BODY TRIMMER"
Not applicable · China · 1 site
Registry update: 9 Nov 2026
NCT07893743
Recruiting
Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.
Not applicable · Denmark · 1 site
Registry update: 26 Oct 2026
NCT07874828
Recruiting
PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
Phase 2 · United States · 1 site
Registry update: 20 Oct 2026
NCT07891156
Recruiting
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Phase 2/3 · Canada · 1 site
Registry update: 23 Oct 2026
NCT07756112
Recruiting
Dynamics of Wound Healing in Patients With Obesity
Not applicable · United States · 1 site
Registry update: 22 Oct 2026
NCT07893106
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight
Phase 1 · United States · 1 site
Registry update: 23 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.